Gold Nanoparticles Triple Cancer Treatment Effectiveness

Scientists at the University of Oklahoma just solved one of cancer treatment's biggest puzzles: how to get medicine inside cancer cells where it can actually work.

The breakthrough centers on tiny gold nanoparticles packaged alongside treatment inside a specialized carrier called an aurniosove. When this carrier enters a cancer cell, the gold particles unlock the cell's "main gate," allowing a flood of therapeutic medicine to rush in instead of sneaking through one molecule at a time.

"The delivery system is like a Trojan horse," said Joshua Seaberg, the doctoral student who created it. His innovation addresses a frustrating problem that has limited cancer treatments for decades.

Getting messenger RNA into cancer cells has always been notoriously difficult, even though once inside, it can instruct cells to self-destruct. Most delivery systems barely crack the door open. Seaberg's aurniosove kicks it wide.

The gold nanoparticles bind to two key proteins inside the cancer cell, triggering a cascade that opens pathways for even more carriers to enter. Testing in laboratory studies and mouse models of ovarian and liver cancer showed the system works exactly as hoped.

Tumors in mice shrank when treated with the aurniosove system. Lab studies confirmed cancer cells absorbed significantly more treatment compared to carriers without gold nanoparticles.

Professor Priyabrata Mukherjee, who leads the research team, encourages his students to think differently about drug delivery. Most researchers view delivery vehicles as passive containers, but Mukherjee saw potential for the carrier itself to become part of the treatment.

The Ripple Effect

This discovery reaches far beyond the specific treatment tested. The aurniosove can carry multiple types of therapies, including chemotherapy and other forms of RNA treatment.

Seaberg designed the system to be adaptable from the start. His team is already testing it with additional cancer-fighting medicines, and they've applied for a patent to protect their fabrication process.

The research, published in Science Advances, represents a fundamental shift in thinking. If delivery systems can actively enhance treatment instead of simply transporting it, researchers worldwide now have a new tool to explore.

"We saw that gap and thought we had a unique approach that could dramatically increase the delivery efficiency," Seaberg said. His approach tackles the many barriers between designing medicine and getting it where it needs to go.

The breakthrough offers hope for more effective cancer treatments with potentially fewer side effects, since medicine reaches its target more efficiently rather than dispersing throughout the body.